EpiSmokEr2: a robust epigenetic classifier for smoking status inference using Illumina EPIC methylation data.

Saved in:
Bibliographic Details
Title: EpiSmokEr2: a robust epigenetic classifier for smoking status inference using Illumina EPIC methylation data.
Authors: Zhu T; Minerva Foundation Institute for Medical Research, Helsinki, Finland.; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Institute of Biotechnology (BI), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Faragó T; Minerva Foundation Institute for Medical Research, Helsinki, Finland.; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Bollepalli S; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Heikkinen A; Minerva Foundation Institute for Medical Research, Helsinki, Finland.; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Hukkanen M; Minerva Foundation Institute for Medical Research, Helsinki, Finland.; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Raitakari O; Centre for Population Health Research, University of Turku and Turku University Hospital, Turku, Finland.; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.; Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland.; InFLAMES Research Flagship, University of Turku, Turku, Finland., Lehtimäki T; Department of Clinical Chemistry, Fimlab Laboratories, and Finnish Cardiovascular Research Center - Tampere, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Korhonen T; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Kaprio J; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland., Fang F; GenOmics and Translational Research Center, RTI International, Research Triangle Park, NC, USA., Lawrence KG; DLH, LLC, Bethesda, MD, USA., Sandler DP; Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA., Spildrejorde MR; Department of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Gervin K; Department of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway., Pan Y; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK., Costeira R; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK., Bell JT; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK., Ollikainen M; Minerva Foundation Institute for Medical Research, Helsinki, Finland.; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Source: Epigenomics [Epigenomics] 2026 Feb; Vol. 18 (2), pp. 205-215. Date of Electronic Publication: 2026 Feb 17.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101519720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-192X (Electronic) Linking ISSN: 1750192X NLM ISO Abbreviation: Epigenomics Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1750-192X
DOI:10.1080/17501911.2026.2630841